Last reviewed · How we verify
NCT03949985: PILL-OFF
Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives
trial testing Tests of biological hemostatic profile associated with contraceptives in Venous Thromboembolism in 103 participants. Completed in 14 September 2020.
14 September 2020
Quick facts
| Lead sponsor | University Hospital, Geneva |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 103 |
| Start date | 8 October 2018 |
| Primary completion | 14 September 2020 |
| Estimated completion | 14 September 2020 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Tests of biological hemostatic profile associated with contraceptives
Conditions studied
- Venous Thromboembolism — all drugs for Venous Thromboembolism →
- Contraception — all drugs for Contraception →
Sponsor
University Hospital, Geneva
Who can join
Adults 18 to 50, female only, with Venous Thromboembolism or Contraception. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective cohort evaluates the longitudinal profile of hemostatic biomarkers during the first 3 months after having stopped a combined oral contraceptive.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives.
Hugon-Rodin J, Fontana P, Poncet A, Streuli I, et al · · 2024 · cited 8× · PMID 37939264 · DOI 10.1182/blood.2023021717
Verify or expand the search:
- PubMed search for NCT03949985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Venous Thromboembolism
Currently open trials in the same condition.
- NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
- NCT06861088 — The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer · Phase 3 · recruiting
- NCT07140523 — A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA · Phase 2 · recruiting
- NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
- NCT06440694 — Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) · Phase 3 · recruiting
Other University Hospital, Geneva trials
Trials by the same sponsor.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
- NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
- NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
- NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03949985 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
- Last refreshed: 21 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03949985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing